title: Pre-exposure rabies vaccination among US international travelers: findings from the global TravEpiNet consortium.
abstract: BACKGROUND
  People who travel to areas with high rabies endemicity and have animal contact are at increased risk for rabies exposure. We examined characteristics of international travelers queried regarding rabies vaccination during pretravel consultations at Global TravEpiNet (GTEN) practices during 2009-2010.
  
  
  METHODS
  We performed bivariate and multivariable analyses of data collected from 18 GTEN clinics. Travel destinations were classified by strength level of rabies vaccination recommendation.
  
  
  RESULTS
  Of 13,235 travelers, 226 (2%) reported previous rabies vaccination, and 406 (3%) received rabies vaccine at the consultation. Common travel purposes for these 406 travelers were leisure (26%), research/education (17%), and nonmedical service work (14%). Excluding the 226 who were previously vaccinated, 8070 (62%) of 13,009 travelers intended to visit one or more countries with a strong recommendation for rabies vaccination; 1675 (21%) of these 8070 intended to travel for 1 month or more. Among these 1675 travelers, 145 (9%) were vaccinated, 498 (30%) declined vaccination, 832 (50%) had itineraries that clinicians determined did not indicate vaccination, and 200 (12%) remained unvaccinated for other reasons. In both bivariate and multivariate analyses, travelers with trip durations >6 months versus 1-3 months (adjusted odds ratio [OR]=4.9 [95% confidence interval [CI] 2.1, 11.4]) and those traveling for "research/education" or to "provide medical care" (adjusted OR=5.1 [95% CI 1.9, 13.7] and 9.5 [95% CI 2.2, 40.8], respectively), compared with leisure travelers, were more likely to receive rabies vaccination.
  
  
  CONCLUSIONS
  Few travelers at GTEN clinics received rabies vaccine, although many planned trips 1 month long or more to a strong-recommendation country. Clinicians often determined that vaccine was not indicated, and travelers often declined vaccine when it was offered. The decision to vaccinate should take into account the strength of the vaccine recommendation at the destination country, duration of stay, availability of postexposure prophylaxis, potential for exposure to animals, and likelihood of recurrent travel to high-risk destinations.
authors.affiliation: 1 Travelers' Health Branch, Division of Global Migration and Quarantine, Centers for Disease Control and Prevention , Atlanta, Georgia .
authors.forename: Samantha B
authors.initials: SB
authors.lastname: Dolan
authors.forename: Emily S
authors.initials: ES
authors.lastname: Jentes
authors.forename: Mark J
authors.initials: MJ
authors.lastname: Sotir
authors.forename: Pauline
authors.initials: P
authors.lastname: Han
authors.forename: Jesse D
authors.initials: JD
authors.lastname: Blanton
authors.forename: Sowmya R
authors.initials: SR
authors.lastname: Rao
authors.forename: Regina C
authors.initials: RC
authors.lastname: LaRocque
authors.forename: Edward T
authors.initials: ET
authors.lastname: Ryan
authors.forename: George M
authors.initials: GM
authors.lastname: Abraham
authors.forename: Salvador
authors.initials: S
authors.lastname: Alvarez
authors.forename: Vernon
authors.initials: V
authors.lastname: Ansdell
authors.forename: Johnnie A
authors.initials: JA
authors.lastname: Yates
authors.forename: Elisha H
authors.initials: EH
authors.lastname: Atkins
authors.forename: John
authors.initials: J
authors.lastname: Cahill
authors.forename: Holly K
authors.initials: HK
authors.lastname: Birich
authors.forename: Dagmar
authors.initials: D
authors.lastname: Vitek
authors.forename: Bradley A
authors.initials: BA
authors.lastname: Connor
authors.forename: Roberta
authors.initials: R
authors.lastname: Dismukes
authors.forename: Phyllis
authors.initials: P
authors.lastname: Kozarsky
authors.forename: Rone
authors.initials: R
authors.lastname: Dosunmu
authors.forename: Jeffrey A
authors.initials: JA
authors.lastname: Goad
authors.forename: Stefan
authors.initials: S
authors.lastname: Hagmann
authors.forename: DeVon
authors.initials: D
authors.lastname: Hale
authors.forename: Noreen A
authors.initials: NA
authors.lastname: Hynes
authors.forename: Frederique
authors.initials: F
authors.lastname: Jacquerioz
authors.forename: Susan
authors.initials: S
authors.lastname: McLellan
authors.forename: Mark
authors.initials: M
authors.lastname: Knouse
authors.forename: Jennifer
authors.initials: J
authors.lastname: Lee
authors.forename: Regina C
authors.initials: RC
authors.lastname: LaRocque
authors.forename: Edward T
authors.initials: ET
authors.lastname: Ryan
authors.forename: Alawode
authors.initials: A
authors.lastname: Oladele
authors.forename: Hanna
authors.initials: H
authors.lastname: Demeke
authors.forename: Roger
authors.initials: R
authors.lastname: Pasinski
authors.forename: Amy E
authors.initials: AE
authors.lastname: Wheeler
authors.forename: Sowmya R
authors.initials: SR
authors.lastname: Rao
authors.forename: Jessica
authors.initials: J
authors.lastname: Rosen
authors.forename: Brian S
authors.initials: BS
authors.lastname: Schwartz
authors.forename: William
authors.initials: W
authors.lastname: Stauffer
authors.forename: Patricia
authors.initials: P
authors.lastname: Walker
authors.forename: Joseph
authors.initials: J
authors.lastname: Vinetz
mesh_terms: D005260:Female; D006801:Humans; D008297:Male; D008889:Military Personnel / Q000706:statistics & numerical data; D009790:Occupations / Q000706:statistics & numerical data; D011818:Rabies / Q000453:epidemiology / Q000517:prevention & control*; D011819:Rabies Vaccines; D018570:Risk Assessment / Q000592:standards; D014195:Travel / Q000706:statistics & numerical data*; D014481:United States; D014611:Vaccination / Q000706:statistics & numerical data*
chemical_list: D011819:Rabies Vaccines